Acurx director gets 2,150 stock options at $2.36
Acurx Pharmaceuticals director James J. Donohue received a stock option grant covering 2,150 shares of common stock as board compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Acurx Pharmaceuticals director James J. Donohue received a stock option grant covering 2,150 shares of common stock as board compensation. The option has an exercise price of $2.36 per share, vests on April 20, 2027, and expires on April 20, 2036. Following the grant, he holds 2,150 stock options directly.
Insider Trade Summary
Grant/Award: 2,150 shares
Grant/Award
1 txn
Insider
Donohue James J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 2,150 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 2,150 contracts (Direct)
Footnotes (1)
- F1. This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027.
Key Figures
Stock options granted: 2,150 options
Exercise price: $2.36 per share
Underlying shares: 2,150 shares
+3 more
6 metrics
Stock options granted
2,150 options
Grant related to board service
Exercise price
$2.36 per share
Strike price for option grant
Underlying shares
2,150 shares
Common stock underlying options
Vesting date
April 20, 2027
Date options become exercisable
Expiration date
April 20, 2036
Option term end date
Options after transaction
2,150 options
Total derivative holdings reported
Key Terms
Stock Option, Director Compensation Policy, vest, exercise price
4 terms
Stock Option financial
"security_title: "Stock Option" with underlying common stock shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Director Compensation Policy financial
"granted pursuant to the Issuer's Director Compensation Policy"
vest financial
"The shares subject to the options shall vest on April 20, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price: "2.3600" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Acurx Pharmaceuticals (ACXP) report for James J. Donohue?
Acurx Pharmaceuticals reported that director James J. Donohue received a stock option grant for 2,150 shares. The award is compensation for board service, not an open-market purchase, and gives the right to buy common shares at a set exercise price.
What are the key terms of James J. Donohue’s new ACXP stock options?
The stock option covers 2,150 shares of Acurx common stock with a $2.36 exercise price. The award vests on April 20, 2027, and expires on April 20, 2036, defining when the director can exercise and when the right ends.
Is the Acurx (ACXP) Form 4 transaction a stock purchase or a grant?
The Form 4 reports a grant of stock options, not a market purchase. Code “A” indicates a grant or award acquisition, giving the director rights to buy shares later at $2.36, subject to the vesting schedule.
When do the newly granted Acurx (ACXP) options to James J. Donohue vest?
The options granted to James J. Donohue vest on April 20, 2027. Vesting means he must remain eligible under the Director Compensation Policy until that date before he can exercise the options for Acurx common shares.
How many Acurx (ACXP) stock options does James J. Donohue hold after this filing?
After this grant, the Form 4 shows James J. Donohue directly holding 2,150 stock options. These options correspond to 2,150 underlying Acurx common shares and reflect his derivative position reported in this specific insider filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates